Chapter 20E - Prescription Drug Monitoring Program
- Section 34-20E-1 - Definition of terms.
- Section 34-20E-2 - Prescription drug monitoring program to be established.
- Section 34-20E-3 - Submission of information to central repository.
- Section 34-20E-4 - Grounds for extension of time to submit information.
- Section 34-20E-5 - Confidentiality of information.
- Section 34-20E-6 - Procedures for security of patent information.
- Section 34-20E-7 - Disclosure of data in central repository to certain persons and entities.
- Section 34-20E-8 - Fees.
- Section 34-20E-9 - Records of information requests.
- Section 34-20E-10 - Contracts to facilitate operation of prescription drug monitoring program.
- Section 34-20E-11 - Immunity from civil liability.
- Section 34-20E-12 - Board to review data and refer patients, prescribers, or dispensers engaged inimproper activities to law enforcement or regulatory authorities.
- Section 34-20E-13 - Correction of erroneous information.
- Section 34-20E-14 - Cooperation with other states.
- Section 34-20E-15 - Advisory council established.
- Section 34-20E-16 - Membership of advisory council.
- Section 34-20E-17 - Recommendations of advisory council.
- Section 34-20E-18 - Report of knowing failure to submit information or submission of incorrectinformation to dispenser's licensing board.
- Section 34-20E-19 - Knowing disclosure of information in violation of chapter as felony.